Synthesis, molecular docking, and preliminary cytotoxicity study of some novel 2-(naphthalen-1-yl)-methylimidazo[2,1-b][1,3,4]thiadiazoles
      
Yazarlar (10)
Choodamani B
Kle College Of Pharmacy, Bengaluru, Hindistan
Sujeet Kumar
Kle College Of Pharmacy, Bengaluru, Hindistan
Alok Kumar Gupta
Kle College Of Pharmacy, Bengaluru, Hindistan
Dominique Schols
Departement Microbiologie, Immunologie En Transplantatie, Belçika
Hakan Tahtacı
Karabük Üniversitesi, Türkiye
Doç. Dr. Tuncay KARAKURT Kırşehir Ahi Evran Üniversitesi, Türkiye
Satvik Kotha
Government College Of Pharmacy, Hindistan
Swapna B
Government College Of Pharmacy, Hindistan
Ramachandra Setty
Government College Of Pharmacy, Hindistan
Subhas S. Karki
Kle College Of Pharmacy, Bengaluru, Hindistan
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Journal of Molecular Structure (Q3)
Dergi ISSN 0022-2860 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 03-2021
Cilt / Sayı / Sayfa 1234 / 1 / 130174–0 DOI 10.1016/j.molstruc.2021.130174
Makale Linki http://dx.doi.org/10.1016/j.molstruc.2021.130174
Özet
A series of 2-(naphthalen-1-yl)-methyl-6-arylimidazo[2,1-b][1,3,4]thiadiazole derivatives was prepared and studied for cytotoxicity against murine leukemia L1210, human cervix carcinoma HeLa, and human T lymphocyte CEM cell lines. The preliminary study showed that compounds 5g, 6g, 7a-c, 7e, and 8e were more potent among the tested compounds. The pharmacokinetic properties of all compounds were then investigated with FAF-Drugs, a tool for prediction of ADME and toxicity. Finally, in order to support in vitro studies, molecular docking studies were performed by using AutoDock Vina with a Lamarckian genetic algorithm to determine whether or not the synthesized compounds could be used as inhibitors for the protein structure 1m17 (EGFR). The docking scores of many compounds were found to be higher than [6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynyl phenyl)amine, an inhibitor of the 1m17 EGFR receptor. Among the selected compounds 7b, 7c, 7e, 7f, 7g, and 8g showed better stability in the molecular dynamics simulation study. (C) 2021 Elsevier B.V. All rights reserved.
Anahtar Kelimeler
Imidazo[2,1-b][1,3,4]thiadiazole | ADME | Molecular docking | Cytotoxicity | Levamisole | Melphalan | Molecular dynamics